TP53 and ovarian carcinoma: Finally, to test whether TP53 MB could provide clinical value for the detection of ovarian cancer in patients with pelvic masses, we built two logistic regression models to compare the predictive value of CA-125 and age versus CA-125, age, and TP53 MB (Table 2).